Articles

PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma

Research Program Unit, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Tampere University Hospital, Finland
Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, Finland
Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
Research Program Unit, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Department of Pathology, Helsinki University Hospital, Finland
Research Program Unit, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland;Science for Life Laboratory, Karolinska Institutet, Department of Oncology and Pathology, Solna, Sweden
Department of Oncology, Tampere University Hospital, Finland;Faculty of Medicine and Life Sciences, University of Tampere, Finland
Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, Finland;Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Research Program Unit, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Research Program Unit, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Comprehensive Cancer Center, Helsinki University Hospital, Finland
Vol. 103 No. 11 (2018): November, 2018 https://doi.org/10.3324/haematol.2018.197194